1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Curaleaf Holdings, Inc.
  6. Summary
    CURA   CA23126M1023

CURALEAF HOLDINGS, INC.

(CURA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  05/16 03:59:49 pm EDT
7.590 CAD   -1.43%
05/10Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/09TRANSCRIPT : Curaleaf Holdings, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09CURALEAF BRIEF : Q1 2022 Revenue of US$313 Million, up 20% YoY; Q1 2022 Adjusted EBITDA of $73 Million, up 16% YoY; And Cash Flow from Operations of US$57.4 Million or 18% of Revenue
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
05/10/2022 05/11/2022 05/12/2022 05/13/2022 05/16/2022 Date
7.29(c) 7.31(c) 7.26(c) 7.7(c) 7.59 Last
805 343 370 063 444 667 542 300 382 493 Volume
0.00% +0.27% -0.68% +6.06% -1.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 445 M - -
Net income 2022 -46,9 M - -
Net Debt 2022 454 M - -
P/E ratio 2022 -78,2x
Yield 2022 -
Sales 2023 1 836 M - -
Net income 2023 46,6 M - -
Net Debt 2023 432 M - -
P/E ratio 2023 213x
Yield 2023 -
Capitalization 4 227 M 4 227 M -
EV / Sales 2022 3,24x
EV / Sales 2023 2,54x
Nbr of Employees -
Free-Float 58,0%
More Financials
Company
Curaleaf Holdings, Inc. is a Canada-based international provider of consumer products in the cannabis market. The Company improves lives by providing cannabis for consumption. The Company and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The Company operates in 23 states with 123 dispensaries and 25 cultivation sites. It... 
Sector
Pharmaceuticals
Calendar
06/23Shareholder meeting
More about the company
Ratings of Curaleaf Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about CURALEAF HOLDINGS, INC.
05/10Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
CI
05/09TRANSCRIPT : Curaleaf Holdings, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09CURALEAF BRIEF : Q1 2022 Revenue of US$313 Million, up 20% YoY; Q1 2022 Adjusted EBITDA of..
MT
05/09CURALEAF BRIEF : Names Matt Darin CEO; Joe Bayern Moves to Head New Division
MT
05/09Curaleaf Holdings, Inc. Announces Revenue Guidance for the Year 2022
CI
05/09Curaleaf Holdings, Inc. Announces Executive Changes
CI
05/09Curaleaf Holdings, Inc. Reports Impairment Loss for the Quarter Ended March 21, 2022
CI
05/06Curaleaf to Open Three New Dispensaries in Florida; Shares Hit 52-Week Low
MT
05/06Curaleaf Holdings, Inc. Expands Retail Presence in Florida with Three New Dispensaries
CI
04/29Curaleaf Opens Two New Florida Dispensaries
MT
04/29Curaleaf Holdings, Inc. Opens Two New Florida Dispensaries in Pembroke Park and Englewo..
CI
04/29Curaleaf International Announces Landmark Registration of Proprietary Range of Cannabis..
BU
04/28CURALEAF : NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT - Form 6-K
PU
04/25CURALEAF : Celebrates The Historic Start Of Adult-Use Cannabis Sales In New Jersey - Form ..
PU
04/21Curaleaf Celebrates the Historic Start of Adult-Use Cannabis Sales in New Jersey
CI
More news
News in other languages on CURALEAF HOLDINGS, INC.
05/10Curaleaf Holdings, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars..
05/09Curaleaf Holdings, Inc. annonce ses prévisions de revenus pour l'année 2022
05/09Curaleaf Holdings, Inc. annonce des changements de direction
05/06Curaleaf va ouvrir trois nouveaux dispensaires en Floride ; les actions atteignent leur..
05/06Curaleaf Holdings, Inc. étend sa présence au détail en Floride avec trois nouveaux disp..
More news
Analyst Recommendations on CURALEAF HOLDINGS, INC.
More recommendations
Chart CURALEAF HOLDINGS, INC.
Duration : Period :
Curaleaf Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CURALEAF HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 5,95 $
Average target price 15,08 $
Spread / Average Target 153%
EPS Revisions
Managers and Directors
Matt Darin President & Chief Executive Officer
Neil P. Davidson Chief Operating & Financial Officer
Boris Alexis Jordan Executive Chairman
Robert Winnicki Senior VP-Research & Product Development
James Shorris Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
CURALEAF HOLDINGS, INC.-31.86%4 227
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421